Freelancer Global Market Research Report Medical Marijuana Market Analysis to 2025w

The Report provides forecast and analysis of the global medical marijuana market. It
provides market overview of global medical marijuana market in terms of revenue (in US$
Mn). Furthermore, the report includes drivers, restraints, trends and opportunity of the
medical marijuana market and their impact on each country during the forecast period.
Medical marijuana refers to cannabis which are specially recommended by doctors for their
patients. Cannabis Indica and Sativa are the two major varieties of the cannabis plant which
are used as medicine across the healthcare industry. From these varieties, there are a huge
number of individual strains, each with a different cannabinoid profile and medicinal effect.
To get a complete report sample https: https://globalmarketforecasts.com/request-for-sample/75
Rising number of marijuana regulations throughout the globe is one of the key factor
propelling the growth of market. With the stream of legalization, the retail and cultivation
sectors have evolved dramatically in the healthcare markets. The market has been
witnessing a significant growth rate over the past few years owing to rise in public
awareness of cannabis for medical use across the globe. Over 500 different chemicals in
cannabis could provide numerous therapeutic benefits across the healthcare industry.
Therefore, increasing clinical studies and research coupled with rising demand for
therapeutic applications of marijuana, will surely escalate the growth of market during the
forecast period.
Top Key Players:-
 AusCann Group Holdings Ltd
 Botanix Pharmaceuticals Limited
 Creso Pharma Ltd
 Hydroponics Co. Ltd.
 Medlab Clinical Ltd
MGC Pharmaceuticals Ltd.
Get more details @ https://globalmarketforecasts.com/selectedReport/75/Global-Medical-
Marijuana-Market-Analysis-and-Forecasts-to-2025-
The global medical marijuana market is segmented into North America, Europe, Asia Pacific,

Latin America, and Middle East & Africa. The North American market is further segmented
into US and Canada. The Europe market is categorized into UK, Germany, and France. The
market for medical marijuana in Asia Pacific is segmented into Japan, China, and India. The
Latin American market is categorized as Mexico and Brazil. The Middle East & Africa region
is classified as South Africa, Saudi Arabia, and UAE.
The study also provides information for recent merger and acquisition deals happened in
the market. Moreover, the report also includes growth strategies and entry barriers to be
considered to cater to the exact business opportunities in this market. Additionally, to aid in